Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences - Arcus Biosciences (NYSE:RCUS) - Benzinga
Arcus Biosciences, Inc. · PHARMACEUTICAL PREPARATIONS · Now $25.34
+11% in 7d after detection
Post-detection moves
1h
—
1d
+4.4%
3d
+3.0%
7d
+11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS